Chairman, Human Oncology and Pathogenesis Program (HOPP)
Memorial Sloan Kettering Cancer Center
1981, graduate, Princeton University; 1985, graduate, Johns Hopkins School of Medicine. Investigator, Howard Hughes Medical Institute. Director, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center. Member: National Academy of Sciences; Institute of Medicine. Co-Recipient, Lasker-Debakey Clinical Research Award (2009) for the development of molecularly targeted treatments for chronic myeloid leukaemia, converting a fatal cancer into a manageable chronic condition.